Nitrendipine

Spécifications

39562-70-4Numéro CAS

254-513-1Numéro CE

5-O-ethyl 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylateNom IUPAC

C18H20N2O6Formule chimique

360.4 g/molMasse molaire

nitrendipine; 39562-70-4; Bayotensin; Baypress; Nidrel; Deiten; 3-ethyl 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nitrendipinum; Bay-e-5009; Nitrendipino; Nitrepin; BAY e 5009; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester; DTXSID0023373; NSC-758466; CHEBI:7582; 9B627AW319; DTXCID203373; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, ethyl methyl ester; nitrendipincorax; NitrePuren; Nitre Puren; nitrendipin corax; O3-ethyl O5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; nitrendipina; Nitrendipinratiopharm; Nitrendipin ratiopharm; Nitrendipin-ratiopharm; RefChem:854225; C08CA08; (A+-)-BAY-E-5009; 254-513-1; 3-Ethyl 5-methyl (4RS)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nitrendipin; Bylotensin; Nitrendipinum [INN-Latin]; Nitrendipino [INN-Spanish]; MFCD00082255; 5-O-ethyl 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; MLS000069349; ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; NCGC00015713-07; SMR000058366; (+/-)-BAY-E-5009; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, ethyl methyl ester, (+/-)-; Baylotensin; Baypress (TN); 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-ethyl 5-methyl ester; SR-01000075334; EINECS 254-513-1; BRN 0498823; Bayotensin;; UNII-9B627AW319; Nitrendipine CRS; Nitrendipine [USAN:INN:BAN:JAN]; CAS-39562-70-4; Spectrum_001901; Nitrendipine (Standard); Opera_ID_928; SpecPlus_000742; Prestwick0_000916; Prestwick1_000916; Prestwick2_000916; Prestwick3_000916; Spectrum2_001565; Spectrum3_000968; Spectrum4_001088; Spectrum5_001655; NITRENDIPINE [MI]; N-144; (.+/-.)-Nitrendipine; NITRENDIPINE [INN]; NITRENDIPINE [JAN]; NITRENDIPINE [USAN]; (+-)-Ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; Ethyl 1,4-dihydro-5-(acetoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridincarboxylat; CBiol_001834; Lopac0_000881; Oprea1_472855; Oprea1_703261; SCHEMBL38972; BSPBio_000792; BSPBio_001399; BSPBio_002575; KBioGR_000119; KBioGR_001476; KBioSS_000119; KBioSS_002432; NITRENDIPINE [MART.]; MLS000759400; MLS001148149; MLS001424133; MLS002153303; MLS002154060; (+/-)-NITRENDIPINE; DivK1c_006838; NITRENDIPINE [WHO-DD]; Nitrendipine, >95%, powder; SPECTRUM1503609; SPBio_001470; SPBio_002981; BPBio1_000872; GTPL2334; orb1225119; orb1310919; orb3025269; CHEMBL3195219; SCHEMBL29465067; HY-B0424R; KBio1_001782; KBio2_000119; KBio2_002426; KBio2_002687; KBio2_004994; KBio2_005255; KBio2_007562; KBio3_000237; KBio3_000238; KBio3_001795; BRD6392; Nitrendipine (JP18/USAN/INN); Bio1_000120; Bio1_000609; Bio1_001098; Bio2_000119; Bio2_000599; HMS1361F21; HMS1570H14; HMS1791F21; HMS1989F21; HMS2051B04; HMS2089H15; HMS2093G17; HMS2097H14; HMS2230F04; HMS3262B04; HMS3266B03; HMS3371J07; HMS3393B04; HMS3402F21; HMS3411I14; HMS3651F05; HMS3675I14; HMS3714H14; HMS3884H21; HMS5081M11; NITRENDIPINE [EP IMPURITY]; Pharmakon1600-01503609; NITRENDIPINE [EP MONOGRAPH]; BRD-6392; HY-B0424; MSK10230; Tox21_110201; Tox21_500881; AC-648; BBL028163; BDBM50237611; CA-212; CCG-39343; EBC-11160; NSC758466; STK368903; AKOS000622913; AKOS015894921; AKOS016340326; Tox21_110201_1; CCG-100991; DB01054; IM57947; KS-1305; LP00881; NC00241; NSC 758466; SDCCGSBI-0050856.P004; IDI1_033869; Nitrendipine for peak identification CRS; O5-ethyl O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; NCGC00015713-04; NCGC00015713-05; NCGC00015713-06; NCGC00015713-08; NCGC00015713-09; NCGC00015713-10; NCGC00015713-11; NCGC00015713-13; NCGC00015713-26; NCGC00024013-02; NCGC00024676-02; NCGC00024676-03; NCGC00024676-04; NCGC00024676-05; NCGC00024676-06; NCGC00024676-07; NCGC00261566-01; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, ethyl methyl ester, (+-)-; IM175687; PD003069; PD033036; ST078195; SY058769; SBI-0050856.P003; Nitrendipine 100 microg/mL in Acetonitrile; AB00513962; EU-0100881; N1186; N3478; NS00007571; S2491; SW219737-1; A10804; C07713; D00629; AB00053154-03; AB00053154_04; AB00053154_05; EN300-18434855; F813117; Q416584; SR-01000075334-1; SR-01000075334-2; SR-01000075334-4; SR-01000075334-6; BRD-A02006392-001-06-5; BRD-A02006392-001-09-9; BRD-A02006392-001-15-6; BRD-A02006392-001-16-4; BRD-A02006392-001-17-2; Z239859926; Nitrendipine, European Pharmacopoeia (EP) Reference Standard; (.+/-.)-Ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; (RS)-Methyl ethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinecarboxylic acid ethyl methyl ester; 3-Ethyl 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate #; 3-ethyl5-methyl2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; methylethyl2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nitrendipine for peak identification, European Pharmacopoeia (EP) Reference Standard; (+/-)-ETHYL METHYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(M-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLATE; (RS)-Methyl ethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate - EP Grade; 2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid ethyl methyl ester; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, ethyl methyl ester, (.+/-.)-; ethyl 5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3 -carboxylateSynonymes